Lexaria Bioscience Corp.

60 Degrees Pharmaceuticals a.r. john hitchings A2Z Cust2Mate Solutions Corp. acquisition acquisitions AiAdvertising alliance global partners Alpine 4 Holdings Alset EHome International Inc American Battery Technology Corporation American Depositary Shares american depository shares Amesite AmpliTech Group anastasia hayes andrew bernstein applied uv inc. Associate atm offering At The Market offering avinger Avital Even-Shoshan Barry Biggar best corporate law firm best lawyers best securities law firm Beyond Air BiondVax Pharmaceuticals biosolar biotech biotricity Blog boustead securities broker Broker Dealer Regulation business business combination Calidi Biotherapeutics cannabis law capital markets Carmel Milazzo Feil LLP carolyn m. glynn cass sanford CBD CEL-SCI Corporation clear law institute closing bell cmf combination common stock common stock and warrants common stock offering Corporate Law corporate law firm corporate lawyers corporate litigation Craft Capital Management LLC Cyngn Inc. D. Boral Capital David B. Manno de-spac Debt devin heck digital ally direct offering EF Hutton elon musk Equillium Equity estate planning ETAO International Group Events Farmmi finra Forza X1 Genetic Technologies Limited Glenn D. Burlingame Greenwich LifeSciences guide H.C. Wainwright & Co. High Tide Inc. immuron immuron limited Inc initial public offering INmune Bio inspire veterinary partners ipo ipo market james turner Jeff D’Angelo jennifer trowbridge jodi zimmerman joseph Nunziata Jupiter Wellness kaspien holdings Kayla Scoccola KULR Technology Group law360 lexaria bioscience litigation LLC Marcelle S. Balcombe marijuana marijuana business marijuana securities Medigus Ltd. mendy piekarski Murphy Canyon Acquisitions Corp. nasdaq NASDAQ: VUZI nasdaq bell ringing Nasdaq Opening Bell nasdaq uplisting network 1 financial securities news NuZee NYC NYC law firm Olivia Marin OMNIQ Corp. Owen A. Kloter pa capital markets pa corporate law group pa exchange act reporting compliance matters pa registration statements pa restricted stock beneficial ownership filings pareteum Partner pa securities law group pharmaceutical pipe PIPES pipes deal pipes law PlacementTracker pr press release private placement Public Offering purchase agreement Qualigen Therapeutics Reg A+ Reg A+ warrant inducement offering registered direct offering regulation best interest Relmada Therapeutics renewable hydrogen Revere Securities Reverse Merger robert birnbaum roth capital partners Ryan Flynn Ryan Houseal sameer rastogi SciSparc Ltd. SEC securities Securities and Exchange Commission Securities Law securities law firm securities lawyers Series B Preferred Stock Sharps Technology ShiftPixy sicheniza ross ference sichenzia sichenzia ross sichenzia ross ference sichenzia ross ference carmel sichenzia ross ference kesner sichenzia ross ference kesner llp sichenzia ross friedman ference singing machine spac Splash Beverage Group Sponsorshop Sports & Entertainment Law Sports & Entertainment Law srf SRFC srff srfk srfk llp srf law srf law firm srf llp Staffing 360 Solutions sunhydrogen Sunshine Biopharma Inc. Tantech Holdings Ltd. Tara Guarneri-Ferrara Tax terra melson tesla The Coretec Group ThinkEquity LLC transaction transactions transactions-prior trusts and estates Twin Vee PowerCats Co. uplisting vuzix vuzix corporation warrants zynex

Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement

October 15, 2024

Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery …

Continue Reading about Sichenzia Ross Ference Carmel LLP represents Lexaria Bioscience Corp. in $5 Million Registered Direct Offering and Concurrent Private Placement →

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering

May 15, 2023

Press Release – New York, NY – May 11, 2023 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp., (NASDAQ: “LEXX”), a global innovator in drug delivery platforms, …

Continue Reading about Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering →